Approval · Notice of Compliance 5967 · 1994
RENEDIL: Notice of Compliance 5967
Issued January 14, 1994
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5967
- Date
- January 14, 1994
- Company
- Hoechst Roussel Canada Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Admin
- Reason
- Revised product monograph
- Therapeutic class
- Antihypertensive agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RENEDIL | Not yet assigned | — |
Medicinal ingredients
- FELODIPINE 5 MG per TAB
- FELODIPINE 10 MG per TAB
- FELODIPINE 2.5 MG per TAB